Loading company details...
Latest Form 4 (Nov 10, 2026): Erica Rossitto (SVP & Chief Nurse Executive): Exercise/Conversion of 8,080 shares, $662.2K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 10, 2026 | Erica Rossitto, SVP & Chief Nurse Executive | Exercise/Conversion | 8,080 | $662.2K |
| Nov 6, 2026 | Patricia F. Elcan | Other (see footnotes) | 886,871 | $446.56M |
| Nov 6, 2026 | Thomas F. Frist III | Other (see footnotes) | 555,500 | $279.71M |
| Nov 6, 2026 | Michael J. Schlosser, EVP and Chief Clinical Officer | Sale | 1,200 | $593.6K |
| Nov 6, 2026 | Jon M. Foster, EVP and COO | Sale | 10,000 | $5.14M |
| Nov 4, 2026 | Mike A. Marks, EVP and CFO | Exercise/Conversion | 4,585 | $375.8K |
| Nov 2, 2026 | Michael J. Schlosser, EVP and Chief Clinical Officer | Exercise/Conversion | 3,030 | $248.3K |
| Aug 28, 2026 | Michael R. McAlevey, EVP & Chief Legal & Admin Off. | Other (see footnotes) | 7,769 | $3.33M |
| May 11, 2026 | Mike A. Marks, EVP and CFO | Gift | 3,336 | n/a |
| Apr 30, 2026 | William R. Frist | Grant/Award | 809 | n/a |